CMPX Compass Therapeutics, Inc.
Compass Therapeutics, Inc. (CMPX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: April 29, 2026 , by Lerner Neil .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Anderman Jonathan | General Counsel | Buy | 25,000 | $1.89 | $47.3K | 196,000 | |
| Lerner Neil | Chief Accounting Officer | Buy | 15,000 | $1.89 | $28.4K | 397,500 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.